An Open-label, Prospective, Uncontrolled Study of the Safety and Local Tolerability of the Diclofenac Epolamine Patch (Flector Patch) in Pediatric Patients With Minor Soft Tissue Injuries
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2017
At a glance
- Drugs Diclofenac hydroxyethylpyrrolidine (Primary)
- Indications Pain
- Focus Adverse reactions
- 06 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 05 Sep 2016 Planned End Date changed from 1 Apr 2016 to 1 Apr 2017.
- 05 Sep 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Apr 2017.